These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27296699)

  • 21. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis.
    Häuser W; Bernardy K; Uçeyler N; Sommer C
    JAMA; 2009 Jan; 301(2):198-209. PubMed ID: 19141768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology and therapy of fibromyalgia. New therapies in fibromyalgia.
    Arnold LM
    Arthritis Res Ther; 2006; 8(4):212. PubMed ID: 16762044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is fibromyalgia part of the climacteric syndrome?
    Blümel JE; Palacios S; Legorreta D; Vallejo MS; Sarra S
    Maturitas; 2012 Oct; 73(2):87-93. PubMed ID: 22771264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised, double-blinded study comparing giving etoricoxib vs. placebo to female patients with fibromyalgia.
    Mahagna H; Amital D; Amital H
    Int J Clin Pract; 2016 Feb; 70(2):163-70. PubMed ID: 26763773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the fibromyalgia syndrome.
    Rao SG; Gendreau JF; Kranzler JD
    Psychopharmacol Bull; 2007; 40(4):24-67. PubMed ID: 18227777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study.
    Hunter AM; Leuchter AF; Cook IA; Abrams M; Siegman BE; Furst DE; Chappell AS
    Pain Med; 2009; 10(4):730-8. PubMed ID: 19453962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EEG biofeedback treatment improves certain attention and somatic symptoms in fibromyalgia: a pilot study.
    Caro XJ; Winter EF
    Appl Psychophysiol Biofeedback; 2011 Sep; 36(3):193-200. PubMed ID: 21656150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.
    Rossini M; Di Munno O; Valentini G; Bianchi G; Biasi G; Cacace E; Malesci D; La Montagna G; Viapiana O; Adami S
    Clin Exp Rheumatol; 2007; 25(2):182-8. PubMed ID: 17543140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential drug therapies for the treatment of fibromyalgia.
    Lawson K
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1071-81. PubMed ID: 27269389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical aspects and management of fibromyalgia syndrome.
    Chong YY; Ng BY
    Ann Acad Med Singap; 2009 Nov; 38(11):967-73. PubMed ID: 19956819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormality of circadian rhythm of serum melatonin and other biochemical parameters in fibromyalgia syndrome.
    Mahdi AA; Fatima G; Das SK; Verma NS
    Indian J Biochem Biophys; 2011 Apr; 48(2):82-7. PubMed ID: 21682138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fibromyalgia syndrome: new developments in pharmacotherapy].
    Harten P
    Z Rheumatol; 2008 Feb; 67(1):75-82. PubMed ID: 17924124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome.
    Smith HS; Harris R; Clauw D
    Pain Physician; 2011; 14(2):E217-45. PubMed ID: 21412381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibromyalgia syndrome: a relevant recent construction of an ancient condition?
    Perrot S
    Curr Opin Support Palliat Care; 2008 Jun; 2(2):122-7. PubMed ID: 18685409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin.
    Arnold LM; Zlateva G; Sadosky A; Emir B; Whalen E
    Pain Med; 2011 Feb; 12(2):260-7. PubMed ID: 21266008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibromyalgia: knowns, unknowns, and current treatment.
    Solitar BM
    Bull NYU Hosp Jt Dis; 2010; 68(3):157-61. PubMed ID: 20969544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Efficacy of Medicinal Cannabis in the Treatment of Fibromyalgia: A Systematic Review.
    Kurlyandchik I; Tiralongo E; Schloss J
    J Altern Complement Med; 2021 Mar; 27(3):198-213. PubMed ID: 33337931
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomised, double-blind, placebo-controlled trial of dolasetron, a 5-hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia.
    Vergne-Salle P; Dufauret-Lombard C; Bonnet C; Simon A; Trèves R; Bonnabau H; Bertin P
    Eur J Pain; 2011 May; 15(5):509-14. PubMed ID: 21036635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibromyalgia: mechanisms, current treatment and animal models.
    Brederson JD; Jarvis MF; Honore P; Surowy CS
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1613-26. PubMed ID: 21466451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation.
    Katz DL; Greene L; Ali A; Faridi Z
    Med Hypotheses; 2007; 69(3):517-25. PubMed ID: 17376601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.